A detailed history of Agf Management LTD transactions in Exelixis, Inc. stock. As of the latest transaction made, Agf Management LTD holds 73,217 shares of EXEL stock, worth $3.15 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
73,217
Holding current value
$3.15 Million
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$32.38 - $39.16 $2.37 Million - $2.87 Million
73,217 New
73,217 $2.7 Million
Q4 2022

Feb 14, 2023

BUY
$14.96 - $17.39 $3.06 Million - $3.56 Million
204,566 New
204,566 $0

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $13.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Agf Management LTD Portfolio

Follow Agf Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Agf Management LTD with notifications on news.